The Oncology Institute, Inc. (TOI)

0.9240 -0.0167 (-1.78%) As of 10:11AM EDT. Market open.

The Oncology Institute, Inc.

18000 Studebaker Road
Suite 800
Cerritos, CA 90703
United States
(562) 735-3226
https://theoncologyinstitute.com

Sector(s): Healthcare
Industry: Medical Care Facilities
Full-time employees: 800

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Richard Alan Barasch	Chairman of the Board	N/A	N/A	1954
Dr. Daniel Virnich FACHE, M.D., MBA	Chief Executive Officer	614.62k	N/A	1979
Mr. Mihir Arunkumar Shah CPA	Chief Financial Officer	505.13k	N/A	1978
Mr. Jordan McInerney	Chief Development Officer	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Corporate governance

The Oncology Institute, Inc.’s ISS governance QualityScore as of 1 May 2024 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder rights: 6; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.